Acute Treatment with Doxorubicin Affects Glutamate Neurotransmission in the Mouse Frontal Cortex and Hippocampus

Doxorubicin (DOX) is a potent chemotherapeutic agent known to cause acute and long-term cognitive impairments in cancer patients. Cognitive function is presumed to be primarily mediated by neuronal circuitry in the frontal cortex (FC) and hippocampus, where glutamate is the primary excitatory neurot...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Brain Res
Egile Nagusiak: Thomas, Theresa Currier, Beitchman, Joshua A., Pomerleau, Francois, Noel, Teresa, Jungsuwadee, Paiboon, Butterfield, D. Allan, Clair, Daret K., Vore, Mary, Gerhardt, Greg A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576558/
https://ncbi.nlm.nih.gov/pubmed/28705715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2017.07.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak